A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Buprenorphine
This two-part training, formerly known as the 8-hour X-Waiver training, is intended to provide eight hours of training for providers seeking to prescribe buprenorphine.
 |
Tuesday, 5/23/2023 8:00 am – 12:00 pm ET |
 |
Virtual event |
 |
Intended AudiencePhysicians (MD, DO), Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants |
Topic: Xylazine
This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Wednesday, 5/24/2023 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Special Populations
This one-hour course is intended to provide foundational knowledge for those working in addiction treatment settings on best practices for creating welcoming spaces to provide addiction care for transgender & gender diverse (TGD) individuals.
|
Wednesday, 5/24/2023 3:00 pm – 4:00 pm ET |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community. |
Topic: Stimulants
This one-hour course is intended to provide foundational knowledge of stimulant use disorders as well as an overview of evidence-based interventions.
|
Thursday, 5/25/2023 1:00 pm – 2:00 pm ET |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community. |
Topic: Addiction 101
This one-hour course is intended to provide foundational knowledge regarding addiction as a chronic medical condition as well as an overview of evidence-based interventions, including medications for addiction treatment (MAT).
|
Tuesday, 5/30/2023 1:00 pm – 2:00 pm ET |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community. |
Topic: Buprenorphine
This training will cover a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
|
Wednesday, 5/31/2023 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine. |
Topic: Family & Social Supports
This training will highlight the importance of family and social support for people with SUD. The importance of evidence-based resources for families will be explained, and concrete and simple changes to current models of addiction treatment to engage the family will be introduced.
|
Wednesday, 5/31/2023 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceAll medical and non-medical staff seeking to learn about the role of the family in addiction treatment are encouraged to attend. |
Topic: Buprenorphine
This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine (Sublocade) in addiction treatment.
|
Wednesday, 5/31/2023 6:00 pm – 7:00 pm ET |
|
Virtual event |
|
Intended AudienceAttendance is required for all OBAT nurses and MAs who work in a DPH/BSAS-funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend. |
Topic: Journal Club
A drop-in session, open to individuals working in the field of addiction. Includes discussion of an evidence-based article with implications for SUD practice.
|
Thursday, 6/1/2023 1:00 pm – 2:00 pm ET |
|
Virtual event |
|
Intended AudienceIndividuals working in the field of addiction medicine. |
Topic: Stimulants
This three-hour course is intended to provide foundational knowledge of stimulant use disorders as well as an overview of evidence-based interventions.
|
Monday, 6/5/2023 2:00 pm – 5:00 pm ET |
|
Virtual event |
|
Intended AudienceMedical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others treating individuals with addiction are welcome and encouraged to attend. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.